Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

ABSTRACT: This study is designed to compare the efficacy and safety of two-weekly RAILIRI regimen with FOLFIRI regimen in the treatment of advanced colorectal cancer patients in the second-line setting.

DISEASE(S): Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2184828 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR